Dfpg Investments LLC bought a new stake in shares of  CVS Health Co. (NYSE:CVS – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 15,155 shares of the pharmacy operator’s stock, valued at approximately $1,360,000.

A number of other large investors also recently added to or reduced their stakes in the business. CWA Asset Management Group LLC increased its stake in shares of  CVS Health by 5.0% in the fourth quarter. CWA Asset Management Group LLC now owns 12,665 shares of the pharmacy operator’s stock worth $1,180,000 after buying an additional 605 shares during the period.  FirstPurpose Wealth LLC increased its position in shares of  CVS Health by 5.9% in the fourth quarter. FirstPurpose Wealth LLC now owns 2,887 shares of the pharmacy operator’s stock valued at $269,000 after acquiring an additional 161 shares during the period.  Gofen & Glossberg LLC IL raised its stake in shares of  CVS Health by 10.1% during the fourth quarter. Gofen & Glossberg LLC IL now owns 34,429 shares of the pharmacy operator’s stock valued at $3,208,000 after acquiring an additional 3,172 shares during the last quarter.  Diversified Trust Co boosted its holdings in shares of  CVS Health by 1.0% during the third quarter. Diversified Trust Co now owns 14,899 shares of the pharmacy operator’s stock worth $1,421,000 after purchasing an additional 145 shares during the period.  Finally, Carnegie Capital Asset Management LLC grew its stake in shares of  CVS Health by 28.9% in the third quarter. Carnegie Capital Asset Management LLC now owns 55,867 shares of the pharmacy operator’s stock worth $5,328,000 after purchasing an additional 12,527 shares during the last quarter. Hedge funds and other institutional investors own  77.29% of the company’s stock.

Several equities research analysts have weighed in on CVS shares. Deutsche Bank Aktiengesellschaft assumed coverage on CVS Health in a report on Monday, April 10th. They issued a “hold” rating for the company. Jefferies Financial Group lifted their price target on shares of CVS Health from $130.00 to $143.00 and gave the company a “buy” rating in a report on Thursday, February 9th. Royal Bank of Canada  restated an “outperform” rating and issued a $115.00 price objective on shares of CVS Health in a report on Thursday, February 9th. Wells Fargo & Company cut their target price on shares of CVS Health from $106.00 to $101.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 3rd. Finally, Morgan Stanley raised their price objective on shares of CVS Health from $119.00 to $120.00 and gave the stock an “overweight” rating in a report on Friday, January 13th. Three equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $118.24.

CVS Health stock opened at $76.14 on Wednesday. CVS Health Co. has a 12 month low of $72.11 and a 12 month high of $107.60. The company has a current ratio of 0.94, a quick ratio of 0.67 and a debt-to-equity ratio of 0.71. The business’s fifty day simple moving average is $80.03 and its two-hundred day simple moving average is $89.28. The company has a market capitalization of $97.45 billion, a price-to-earnings ratio of 24.40, a price-to-earnings-growth ratio of 1.16 and a beta of 0.61.

CVS Health (NYSE:CVS – Get Rating) last announced its quarterly earnings results on Wednesday, February 8th. The pharmacy operator reported $1.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.92 by $0.07. The company had revenue of $83.85 billion for the quarter, compared to analysts’ expectations of $76.37 billion. CVS Health had a net margin of 1.29% and a return on equity of 15.75%. CVS Health’s revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.98 EPS.  As a group, equities analysts predict that  CVS Health Co. will post 8.77 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, May 1st. Stockholders of record on Friday, April 21st will be paid a $0.605 dividend. This represents a $2.42 annualized dividend and a dividend yield of 3.18%. The ex-dividend date of this dividend is Thursday, April 20th. CVS Health’s dividend payout ratio  is currently 77.56%.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.